Epstein-Barr virus in the pathogenesis of NPC

Seminars in Cancer Biology

Volumn 12, Issue 6, 2002, Pages 431-441

  Raab Traub, Nancy ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Epstein Barr virus; Hodgkin's disease; Latent membrane proteins 1 and 2; Nasopharyngeal carcinoma

Indexed keywords

ISOPROTEIN; LATENT MEMBRANE PROTEIN 1; VIRUS ANTIGEN; VIRUS DNA; VIRUS PROTEIN;

CANCER CLASSIFICATION; CELL GROWTH; CONFERENCE PAPER; DNA DETERMINATION; EPSTEIN BARR VIRUS; GENE EXPRESSION; HUMAN; LONG TERMINAL REPEAT; NASOPHARYNX CARCINOMA; NONHUMAN; PATHOGENESIS; VIRUS GENE; VIRUS INFECTION;

EID: 0036435166     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1044579X0200086X     Document Type: Conference Paper

References (102)

1. Rickinson AB, Kieff E (2001) Epstein-Barr virus, in Field's Virology, 4th edn (Knipe DM, Howley PM, eds) pp. 2575-2627. Lippincott/Williams & Wilkins, Philadelphia, PA
2. Henle G, Henle W (1976) Epstein-Barr virus-specific IgA antibodies as an outstanding feature of nasopharyngeal carcinoma. Int J Cancer 17:1-7
3. Kieff E, Rickinson AB (2001) Epstein-Barr virus and its replication, in Field's Virology, vol 2 (Knipe DM, Howley PM, eds) pp. 2511-2573. Lippincott/Williams & Wilkins, Philadelphia, PA
4. Yates JL, Warren N, Sugden B (1985) Stable replication of plas-mids derived from Epstein-Barr virus in various mammalian cells. Nature 313:812-815
5. Sample JHM, Braun D, Birkenbach M, Kieff E (1986) Nucleotide sequences of mRNAs encoding Epstein-Barr virus nuclear proteins: A probable transcriptional initiation site. Proc Natl Acad Sci USA 83:5096-5100
6. Grossman SR, Johannsen E, Tong X, Yalamanchili R, Kieff E (1994) The Epstein-Barr virus nuclear antigen 2 transactivator is directed to response elements by the J kappa recombination signal binding protein. Proc Natl Acad Sci USA 91:7568-7572
7. Henkel T, Ling PD, Hayward SD, Peterson MG (1994) Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein J kappa. Science 265:92-95
8. Dambaugh T, Hennessy K, Chamnankit L, Kieff E (1984) U2 region of Epstein-Barr virus DNA may encode Epstein-Barr nuclear antigen 2. Proc Natl Acad Sci USA 81:7632-7636
9. Young LS, Yao QY, Rooney CM et al. (1987) New type B isolates of Epstein-Barr virus from Burkitt's lymphoma and from normal individuals in endemic areas. J Gen Virol 68:2853-2862
10. Abdel-Hamid M, Chen JJ, Constantine N, Massoud M, Raab-Traub N (1992) EBV strain variation: geographical distribution and relation to disease state. Virology 190:168-175
11. Walling DM, Edmiston SN, Sixbey JW, Abdel-Hamid M, Resnick L, Raab-Traub N (1992) Coinfection with multiple strains of the Epstein-Barr virus in human immunodeficiency virus-associated hairy leukoplakia. Proc Natl Acad Sci USA 89:6560-6564
12. Sample J, Young L, Martin B, Chatman T, Kieff E, Rickin-son A (1990) Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes. J Virol 64:4084-4092
13. Rowe M, Young LS, Cadwallader K, Petti L, Kieff E, Rickin-son AB (1989) Distinction between Epstein-Barr virus type A (EBNA 2A) and type B (EBNA 2B) isolates extends to the EBNA 3 family of nuclear proteins. J Virol 63:1031-1039
14. Wang F, Gregory C, Sample C et al. (1990) Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23. J Virol 64:2309-2318
15. Robertson ES, Grossman S, Johannsen E et al. (1995) Epstein-Barr virus nuclear protein 3C modulates transcription through interaction with the sequence-specific DNA-binding protein J kappa. J Virol 69:3108-3116
16. Robertson ES, Lin J, Kieff E (1996) The amino-terminal domains of Epstein-Barr virus nuclear proteins 3A, 3B, and 3C interact with RBPJ(kappa). J Virol 70:3068-3074
17. Murray RJ, Kurilla MG, Brooks JM et al. (1992) Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies. J Exp Med 176:157-168
18. Wang D, Liebowitz D, Kieff E (1985) An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 43:831-840
19. Dawson CW, Rickinson AB, Young LS (1990) Epstein-Barr virus latent membrane protein inhibits human epithelial cell differentiation. Nature 344:777-780
20. Fahraeus R, Rymo L, Rhim JS, Klein G (1990) Morphological transformation of human keratinocytes expressing the LMP gene of Epstein-Barr virus. Nature 345:447-449
21. Miller WE, Earp HS, Raab-Traub N (1995) The Epstein-Barr virus latent membrane protein 1 induces expression of the epidermal growth factor receptor. J Virol 69:4390-4398
22. Fahraeus R, Chen W, Trivedi P, Klein G, Obrink B (1992) Decreased expression of E-cadherin and increased invasive capacity in EBV-LMP-transfected human epithelial and murine adenocarcinoma cells. Int J Cancer 52:834-838
23. Eliopoulos AG, Stack M, Dawson CW et al. (1997) Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-kappaB pathway involving TNF receptor-associated factors. Oncogene 14:2899-2916
24. Henderson S, Rowe M, Gregory C et al. (1991) Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 65:1107-1115
25. Fries KL, Miller WE, Raab-Traub N (1996) Epstein-Barr virus latent membrane protein 1 blocks p53-mediated apoptosis through the induction of the A20 gene. J Virol 70:8653-8659
26. Okan I, Wang Y, Chen F et al. (1995) The EBV-encoded LMP1 protein inhibits p53-triggered apoptosis but not growth arrest. Oncogene 11:1027-1031
27. Effert P, McCoy R, Abdel-Hamid M et al. (1992) Alterations of the p53 gene in nasopharyngeal carcinoma. J Virol 66:3768-3775
28. Huen DS, Henderson SA, Croom-Carter D, Rowe M (1995) The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-kappa B and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain. Oncogene 10:549-560
29. Mosialos G, Birkenbach M, Yalamanchili R, VanArsdale T, Ware C, Kieff E (1995) The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell 80:389-399
30. Izumi KM, Kieff ED (1997) The Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-kappaB. Proc Natl Acad Sci USA 94:12592-12597
31. Miller WE, Mosialos G, Kieff E, Raab-Traub N (1997) Epstein-Barr virus LMP1 induction of the epidermal growth factor receptor is mediated through a TRAF signaling pathway distinct from NF-kappaB activation. J Virol 71:586-594
32. Eliopoulos AG, Young LS (1998) Activation of the cJun N-terminal kinase (JNK) pathway by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1). Oncogene 16:1731-1742
33. Laux G, Perricaudet M, Farrell PJ (1988) A spliced Epstein-Barr virus gene expressed in immortalized lymphocytes is created by circularization of the linear viral genome. EMBO J 7:769-774
34. Miller CL, Lee JH, Kieff E, Burkhardt AL, Bolen JB, Long-necker R (1994) Epstein-Barr virus protein LMP2A regulates reactivation from latency by negatively regulating tyrosine kinases involved in sIg-mediated signal transduction. Infect Agents Dis 3:128-136
35. Scholle F, Longnecker R, Raab-Traub N (1999) Epithelial cell adhesion to extracellular matrix proteins induces tyrosine phosphorylation of the Epstein-Barr virus latent membrane protein 2: A role for C-terminal Src kinase. J Virol 73:4767-4775
36. Scholle F, Raab-Traub N (2000) Epstein-Barr virus LMP2A transforms epithelial cells, inhibits cell differentiation, and activates Akt. J Virol 74:10681-10689
37. Arrand JR, Rymo L (1982) Characterization of the major Epstein-Barr virus-specific RNA in Burkitt lymphoma-derived cells. J Virol 41:376-389
38. Swaminathan S, Tomkinson B, Kieff E (1991) Recombinant Epstein-Barr virus with small RNA (EBER) genes deleted transforms lymphocytes and replicates in vitro. Proc Natl Acad Sci USA 88:1546-1550
39. Pathmanathan R, Prasad U, Chandrika G, Sadler R, Flynn K, Raab-Traub N (1995) Undifferentiated, nonkeratinizing, and squamous cell carcinoma of the nasopharynx. Variants of Epstein-Barr virus-infected neoplasia. Am J Pathol 146:1355-1367
40. Gilligan K, Rajadurai P, Resnick L, Raab-Traub N (1990) Epstein-Barr virus small nuclear RNAs are not expressed in permissively infected cells in AIDS-associated leukoplakia. Proc Natl Acad Sci USA 87:8790-8794
41. Komano J, Sugiura M, Takada K (1998) Epstein-Barr virus contributes to the malignant phenotype and to apoptosis resistance in Burkitt's lymphoma cell line Akata. J Virol 72:9150-9156
42. Komano J, Maruo S, Kurozumi K, Oda T, Takada K (1999) Oncogenic role of Epstein-Barr virus-encoded RNAs in Burkitt's lymphoma cell line Akata. J Virol 73:9827-9831
43. Li QX, Young LS, Niedobitek G et al. (1992) Epstein-Barr virus infection and replication in a human epithelial cell system. Nature 356:347-350
44. Sixbey JW, Nedrud JG, Raab-Traub N, Hanes RA, Pagano JS (1984) Epstein-Barr virus replication in oropharyngeal epithelial cells. New Engl J Med 310:1225-1230
45. Wolf H, Haus M, Wilmes E (1984) Persistence of Epstein-Barr virus in the parotid gland. J Virol 51:795-798
46. Miller G, Niederman JC, Andrews LL (1973) Prolonged oropharyngeal excretion of Epstein-Barr virus after infectious mononucleosis. New Engl J Med 288:229-232
47. Tao Q, Srivastava G, Chan AC, Chung LP, Loke SL, Ho FC (1995) Evidence for lytic infection by Epstein-Barr virus in mucosal lymphocytes instead of nasopharyngeal epithelial cells in normal individuals. J Med Virol 45:71-77
48. Henry SSC, Berrajah L, Karray H, Drira M, Hammami A, Icart J, Mariame B (2001) In nasopharyngeal carcinoma-bearing patients, tumors and lymphocytes are infected by different Epstein-Barr virus strains. Int J Cancer 91:698-704
49. Sacaze CHS, Icart J, Mariame B (2001) Tissue specific distribution of Epstein-Barr virus (EBV) BZLF1 gene variants in nasopharyngeal carcinoma (NPC) bearing patients. Virus Res 81:133-142
50. Chen HL, Lung ML, Chan KH, Griffin BE, Ng MH (1996) Tissue distribution of Epstein-Barr virus genotypes. J Virol 70:7301-7305
51. Wen S, Mizugaki Y, Shinozaki F, Takada K (1997) Epstein-Barr virus (EBV) infection in salivary gland tumors: lytic EBV infection in nonmalignant epithelial cells surrounded by EBV-positive T-lymphoma cells. Virology 227:484-487
52. Greenspan JS, Greenspan D, Lennette ET et al. (1985) Replication of Epstein-Barr virus within the epithelial cells of oral hairy leukoplakia, an AIDS-associated lesion. New Engl J Med 313:1564-1571
53. Walling DMFC, Nichols CM, Hudnall SD, Adler-Storthz K (2001) Persistent productive Epstein-Barr virus replication in normal epithelial cells in vivo. J Infect Dis 184:1499-1507
54. Sam CK, Brooks LA, Niedobitek G, Young LS, Prasad U, Rick-inson AB (1993) Analysis of Epstein-Barr virus infection in na-sopharyngeal biopsies from a group at high risk of nasopha-ryngeal carcinoma. Int J Cancer 53:957-962
55. Shanmugaratnam K (1978) Histological typing of nasopharyn-geal carcinoma. IARC Sci Publ 20:3-12
56. Krueger GR, Kottaridis SD, Wolf H, Ablashi DV, Sesterhenn K, Bertram G (1981) Histological types of nasopharyngeal carcinoma as compared to EBV serology. Anticancer Res 1:187-194
57. Pearson GR, Weiland LH, Neel HBD et al. (1983) Application of Epstein-Barr virus (EBV) serology to the diagnosis of North American nasopharyngeal carcinoma. Cancer 51:260-268
58. Sam CK, Prasad U, Pathmanathan R (1989) Serological markers in the diagnosis of histopathological types of nasopharyn-geal carcinoma. Eur J Surg Oncol 15:357-360
59. Nonoyama M, Huang CH, Pagano JS, Klein G, Singh S (1973) DNA of Epstein-Barr virus detected in tissue of Burkitt's lym-phoma and nasopharyngeal carcinoma. Proc Natl Acad Sci USA 70:3265-3268
60. Wolf H, Hausen HZ, Becker V (1973) EB viral genomes in epithelial nasopharyngeal carcinoma cells. Nat New Biol 244:245-247
61. Klein G, Giovanella BC, Lindahl T, Fialkow PJ, Singh S, Stehlin JS (1974) Direct evidence for the presence of Epstein-Barr virus DNA and nuclear antigen in the malignant epithelial cells from patients with poorly differentiated carcinoma of the nasopharynx. Proc Natl Acad Sci USA 71:4737-4741
62. Desgranges C, de-The G, Wolf H, zur Hausen H (1975) Further studies on the detection of the Epstein-Barr virus DNA in nasopharyngeal carcinoma biopsies from different parts of the world. IARC Sci Publ 11:191-193
63. Raab-Traub N, Flynn K, Pearson G et al. (1987) The differentiated form of nasopharyngeal carcinoma contains Epstein-Barr virus DNA. Int J Cancer 39:25-29
64. Niedobitek G, Hansmann ML, Herbst H et al. (1991) Epstein-Barr virus and carcinomas: undifferentiated carcinomas but not squamous cell carcinomas of the nasopharynx are regularly associated with the virus. J Pathol 165:17-24
65. Gulley ML, Amin MB, Nicholls JM et al. (1995) Epstein-Barr virus is detected in undifferentiated nasopharyngeal carcinoma but not in lymphoepithelioma-like carcinoma of the urinary bladder. Hum Pathol 26:1207-1214
66. Adams A, Lindahl T (1975) Epstein-Barr virus genomes with properties of circular DNA molecules in carrier cells. Proc Natl Acad Sci USA 72:1477-1481
67. Sato H, Takimoto T, Tanaka S, Tanaka J, Raab-Traub N (1990) Concatameric replication of Epstein-Barr virus: structure of the termini in virus-producer and newly transformed cell lines. J Virol 64:5295-5300
68. Kaschka-Dierich C, Adams A, Lindahl T et al. (1976) Intracel-lular forms of Epstein-Barr virus DNA in human tumour cells in vivo. Nature 260:302-306
69. Raab-Traub N, Flynn K (1986) The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell 47:883-889
70. Given D, Yee D, Griem K, Kieff E (1979) DNA of Epstein-Barr virus. V. Direct repeats of the ends of Epstein-Barr virus DNA. J Virol
71. Kripalani-Joshi S, Law HY (1994) Identification of integrated Epstein-Barr virus in nasopharyngeal carcinoma using pulse field gel electrophoresis. Int J Cancer 56:187-192
72. Pathmanathan R, Prasad U, Sadler R, Flynn K, Raab-Traub N (1995) Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carci - noma [see comments]. New Engl J Med 333:693-698
73. Yeung WM, Zong YS, Chiu CT et al. (1993) Epstein-Barr virus carriage by nasopharyngeal carcinoma in situ. Int J Cancer 53:746-750
74. Raab-Traub N, Hood R, Yang CS, Henry BD, Pagano JS (1983) Epstein-Barr virus transcription in nasopharyngeal carcinoma. J Virol 48:580-590
75. Wu TC, Mann RB, Epstein JI et al. (1991) Abundant expression of EBER1 small nuclear RNA in nasopharyngeal carcinoma. A morphologically distinctive target for detection of Epstein-Barr virus in formalin-fixed paraffin-embedded carcinoma specimens. Am J Pathol 138:1461-1469
76. Brooks L, Yao QY, Rickinson AB, Young LS (1992) Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts. J Virol 66:2689-2697
77. Sadler RH, Raab-Traub N (1995) Structural analyses of the Epstein-Barr virus BamHI A transcripts. J Virol 69:1132-1141
78. Fahraeus R, Fu HL, Emberg I et al. (1988) Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma. Int J Cancer 42:329-338
79. Young LS, Dawson CW, Clark D et al. (1988) Epstein-Barr virus gene expression in nasopharyngeal carcinoma. J Gen Virol 69:1051-1065
80. Frech B, Zimber-Strobl U, Yip TT, Lau WH, Mueller-Lantzsch N (1993) Characterization of the antibody response to the latent infection terminal proteins of Epstein-Barr virus in patients with nasopharyngeal carcinoma. J Gen Virol 74:811-818
81. Sample J, Brooks L, Sample C, et al (1991) Restricted Epstein-Barr virus protein expression in Burkitt lymphoma is due to a different Epstein-Barr nuclear antigen 1 transcriptional initiation site. Proc Natl Acad Sci USA 88:6343-6347
82. Smith PR, Griffin BE (1992) Transcription of the Epstein-Barr virus gene EBNA-1 from different promoters in nasopharyngeal carcinoma and B-lymphoblastoid cells. J Virol 66:706-714
83. Wang F, Tsang SF, Kurilla MG, Cohen JI, Kieff E (1990) Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1. J Virol 64:3407-3416
84. Gilligan K, Sato H, Rajadurai P et al. (1990) Novel transcription from the Epstein-Barr virus terminal EcoRI fragment, DIJhet, in a nasopharyngeal carcinoma. J Virol 64:4948-4956
85. Sadler RH, Raab-Traub N (1995) The Epstein-Barr virus 3.5-kilobase latent membrane protein 1 mRNA initiates from a TATA-less promoter within the first terminal repeat. J Virol 69:4577-4581
86. Chen HLJ, Zong Y, Borowitz M, Ng MH, Ambinder RF, Hayward SD (2001) Linkage between STAT regulation and Epstein-Barr virus gene expression in tumors. J Virol 75:2929-2937
87. Hitt MM, Allday MJ, Hara T et al. (1989) EBV gene expression in an NPC-related tumour. EMBO J 8:2639-2651
88. Gilligan KJ, Rajadurai P, Lin JC et al. (1991) Expression of the Epstein-Barr virus BamHI A fragment in nasopharyngeal carcinoma: evidence for a viral protein expressed in vivo. J Vi-rol 65:6252-6259
89. Smith PR, Gao Y, Karran L, Jones MD, Snudden D, Griffin BE (1993) Complex nature of the major viral poly-adenylated transcripts in Epstein-Barr virus-associated tumors. J Virol 67:3217-3225
90. Zhang JCH, Weinmaster G, Hayward SD (2001) Epstein-Barr virus BamHI-A rightward transcript-encoded RPMS protein interacts with the CBF1-associated corepressor CIR to negatively regulate the activity of EBNA2 and NotchIC. J Virol 75:2946-2956
91. Smith PR, de Jesus O, Turner D et al. (2000) Structure and coding content of CST (BART) family RNAs of Epstein-Barr virus. J Virol 74:3082-3092
92. Kusano SRTN (2001) An Epstein-Barr virus protein interacts with Notch in epithelial cells. J Virol 75:384-395
93. Lung ML, Chang RS, Huang ML et al. (1990) Epstein-Barr virus genotypes associated with nasopharyngeal carcinoma in southern China. Virology 177:44-53
94. Hu LF, Zabarovsky ER, Chen F et al. (1991) Isolation and sequencing of the Epstein-Barr virus BNLF-1 gene (LMP1) from a Chinese nasopharyngeal carcinoma. J Gen Virol 72:2399-2409
95. Miller WE, Edwards RH, Walling DM, Raab-Traub N (1994) Sequence variation in the Epstein-Barr virus latent membrane protein 1. J Gen Virol 75:2729-2740
96. Sung NS, Edwards RH, Seillier-Moiseiwitsch F, Perkins AG, Zeng Y, Raab-Traub N (1998) Epstein-Barr virus strain variation in nasopharyngeal carcinoma from the endemic and non-endemic regions of China. Int J Cancer 76:207-215
97. Cheung ST, Leung SF, Lo KW et al. (1998) Specific latent membrane protein 1 gene sequences in type 1 and type 2 Epstein-Barr virus from nasopharyngeal carcinoma in Hong Kong. Int J Cancer 76:399-406
98. Edwards RH, Seillier-Moiseiwitsch F, Raab-Traub N (1999) Signature amino acid changes in latent membrane protein 1 distinguish Epstein-Barr virus strains. Virology 261:79-95
99. Sandvej K, Gratama JW, Munch M et al. (1997) Sequence analysis of the Epstein-Barr virus (EBV) latent membrane protein-1 gene and promoter region: identification of four variants among wild-type EBV isolates. Blood 90:323-330
100. Li SN, Chang YS, Liu ST (1996) Effect of a 10-amino acid deletion on the oncogenic activity of latent membrane protein 1 of Epstein-Barr virus. Oncogene 12:2129-2135
101. Miller WE, Cheshire JL, Baldwin Jr AS, Raab-Traub N (1998) The NPC derived C15 LMP1 protein confers enhanced activation of NF-kappa B and induction of the EGFR in epithelial cells. Oncogene 16:1869-1877
102. Johnson RJ, Stack M, Hazlewood SA et al. (1998) The 30-base-pair deletion in Chinese variants of the Epstein-Barr virus LMP1 gene is not the major effector of functional differences between variant LMP1 genes in human lymphocytes. J Virol 72:4038-4048